Ignite Creation Date:
2024-05-06 @ 8:05 PM
Last Modification Date:
2024-10-26 @ 3:20 PM
Study NCT ID:
NCT06241898
Status:
RECRUITING
Last Update Posted:
2024-02-05
First Post:
2024-01-28
Brief Title:
A First-in-human of Multiplle Doses of BB-1709 in Subjects With Locally AdvancedMetastatic Solid Tumors
Sponsor:
Bliss Biopharmaceutical Hangzhou Co Ltd
Organization:
Bliss Biopharmaceutical Hangzhou Co Ltd
Organization Data
Organization:
Bliss Biopharmaceutical Hangzhou Co Ltd
Class:
INDUSTRY
Study ID:
bliss
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Bliss Biopharmaceutical Hangzhou Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None